Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Special notice

TECHNOLOGY LICENSING OPPORTUNITY: Peptoid-Based Chelating Ligands for Selective Metal Chelation

S-133639

Department of Energy, Triad - DOE Contractor. Research and Development in Biotechnology (except Nanobiotechnology).

Response deadline

June 30, 2026 at 7:00 PM EDT

Closed 124 days ago. Posted May 12, 2026. Scheduled to archive September 30, 2027.

Get the next one like this from Department of Energy by email, the day it is posted.Find my opportunities

This one closed in 2026

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

Peptoid-based chelating ligands offer a tunable platform for capturing and holding specific metal ions with high selectivity while resisting breakdown under physiological conditions. The technology combines structural flexibility with strong binding performance, which creates a practical path for applications where existing chelators fall short, including difficult metal removal in biological, environmental and separation settings.

How it Works

Peptoid-Based Chelating Ligands uses cyclic peptoid scaffolds, which are peptoid chains closed into ring structures and decorated with side chains chosen for metal binding. By changing the ring size, side-chain chemistry and spacing between binding groups, the ligand can be adjusted to favor certain hard metal ions, especially actinides and lanthanides.

Technical Description

Peptoids differ from peptides because their side chains attach to nitrogen rather than to carbon, which makes them more resistant to hydrolysis under physiological conditions. That stability matters because many conventional chelators can lose activity in the body or in harsh process streams, while peptoid-based structures are designed to remain intact long enough to bind and hold the target metal.

The invention describes cyclic peptoid ligands that can be built from linear peptoids and then cyclized, with the binding profile tuned through functional groups such as catecholates, phosphonates, amines, guanidinium groups, phosphoramidates, N-hydroxypyridones and CMPO-like groups. Linker length, hydrophobicity, hydrophilicity and the number of coordinating groups can be adjusted to improve selectivity for specific ions and to support either tight retention for removal or controlled release after capture.

Advantages

  • Strong selectivity for hard metal ions, including actinides and lanthanides
  • Greater resistance to hydrolysis than many natural chelators
  • Modular design that allows tuning for different metals and uses
  • Potential use across medical, imaging and separation applications
  • Ability to adjust water compatibility or lipid compatibility depending on the target environment
  • Built from a platform chemistry that can be adapted to different side-chain combinations

Market Applications

  • Environmental Remediation and Waste Handling (actinide capture and metal cleanup)
  • Medical Chelation Therapy (treatment support for metal poisoning)
  • Medical Imaging (contrast-agent development)
  • Drug Delivery (carrier or targeting chemistry)
  • Separations and Purification (selective recovery of valuable metals)
  • Radiotherapy Support (targeted metal-based delivery systems)

TRL 4

US Patent Nos. 11,254,708; 11,859,018

LA-UR-26-23913

LANL Tech Partnerships: Unlock the Innovative Potential

Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products.

LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov.

Note: This is not a call for external services for the development of this technology.

https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology

m.lanl.gov/tech-search

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 12, 2026

    Special notice

    Due June 30, 2026 at 7:00 PM EDT. SAM.gov, notice 134191a3adcb4f51ab267135f6d846f1

    1 revisions on SAM
    • May 12, 2026: publish, special notice

Points of contact